INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
YN

York Charles N II

COO and CFOCIK 0001655962

EDGAR filingsOpen in network
Disclosed transactions23
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Day One Biopharmaceuticals, Inc.COO and CFO · Nov 7, 2025
9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D
—
497.7K sh
Apr 23, 2026
Apr 23, 2026
traded Apr 23, 2026
+0d
SEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
151.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
116.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
188.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
6,750 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
46.4K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
72.9K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
118.1K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
312.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
188.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
126.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
162.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
497.7K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
497.7K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
151.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
151.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
116.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
116.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
162.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence